Loma Linda University
OrganisationROR
People
Professor
Lead investigator
Sources: reporter.nih.gov, openalex.org
Trials
Collaborator, Phase 2, Recruiting, 210 people, 25 Sept 2026
The Effects of Mango on Gut Health Markers
Not yet recruiting, 31 people, 30 Apr 2026
Phase 4, Not yet recruiting, 100 people, 13 Aug 2024
Phase 4, Recruiting, 98 people, 22 May 2023
Phase 2/3, Withdrawn, 0 people, 27 Oct 2021
Phase 3, Completed, 119 people, 21 Oct 2021
Phase 4, Recruiting, 98 people, 26 Apr 2021
Phase 2, Withdrawn, 0 people, 20 Apr 2020
Phase 4, Completed, 1,307 people, 15 Oct 2019
Phase 2, Terminated, 23 people, 16 May 2019
Phase 3, Completed, 90 people, 26 Jul 2018
Phase 3, Completed, 185 people, 19 Jan 2018
Phase 1, Completed, 3 people, 3 Feb 2016
Early phase 1, Withdrawn, 0 people, 4 Sept 2015
Phase 2, Withdrawn, 0 people, 9 Dec 2014
Phase 4, Withdrawn, 0 people, 21 Apr 2014
Collaborator, Phase 1, Completed, 125 people, 5 Nov 2013
Completed, 708 people, 6 Jul 2012
Phase 4, Terminated, 15 people, 24 Sept 2009
Phase 2, Terminated, 7 people, 15 Jan 2009
Sources: clinicaltrials.gov
Grants and prizes
R01, Role of Endothelial K+ Channels in Age-Related Dementia, R01AG073230, US$622.1k, 2022–2027, 11 May 2026
Innovative Project Award, A novel approach of generating and epigenomic characterization of cardiomycytes from human peripheral blood cells, 18IPA34170301, US$200k, 2018–2020, 1 Jul 2018
Sources: reporter.nih.gov, openalex.org